| 注册
首页|期刊导航|北京中医药大学学报|中医药降低早期糖尿病肾病患者蛋白尿水平疗效的Meta分析∗

中医药降低早期糖尿病肾病患者蛋白尿水平疗效的Meta分析∗

代晓颖 张燕 易静 唐丽灵 何丽芳

北京中医药大学学报Issue(2):144-150,7.
北京中医药大学学报Issue(2):144-150,7.DOI:10.3969/j.issn.1006-2157.2016.02.012

中医药降低早期糖尿病肾病患者蛋白尿水平疗效的Meta分析∗

Effects of Chinese medicine on proteinuria in patients with early diabetic nephropathy:a meta-analysis

代晓颖 1张燕 1易静 1唐丽灵 2何丽芳2

作者信息

  • 1. 重庆医科大学公共卫生与管理学院 医学与社会发展研究中心 健康领域社会风险预测治理协同创新中心 重庆400016
  • 2. 重庆市卫生和计划生育委员会
  • 折叠

摘要

Abstract

Objective To evaluate the effects of Traditional Chinese Medicine ( TCM) on proteinuria in patients with early diabetic nephropathy ( DN ) by using meta-analysis. Methods All publications of randomized controlled trials ( RCTs) studying traditional Chinese medicine in the treatment of early dia-betic nephropathy were searched and identified from Medline, PubMed, Cochrane Library, CBM, VIP and CNKI. The quality of included studies were evaluated by using revised Jadad scale. Rev. Man 5. 3 software was used for meta-analysis. Results A total of 27 RCTs involving 1 824 patients with early DN were included. Meta-analysis results showed that TCM treatment group could reduce the level of urine al-bumin excretion rate (UAER) and 24h urine albumin level with or without using angiotensin converting enzyme inhibitor and angiotensin receptor blocker ( ACEI/ARB) , when compared to control group using ACEI/ARB only. No serious adverse reactions were observed in TCM treatment groups. Conclusion It was proved that the efficiency and safety of traditional Chinese medicine on proteinuria in patients with early diabetic nephropathy.

关键词

早期糖尿病肾病/中医药/Meta分析/血管紧张素转化酶抑制剂/血管紧张素Ⅱ受体拮抗剂/随机对照试验

Key words

early diabetic nephropathy/traditional Chinese medicine/meta-analysis/ACEI/ARB/ran-domized controlled trials

分类

医药卫生

引用本文复制引用

代晓颖,张燕,易静,唐丽灵,何丽芳..中医药降低早期糖尿病肾病患者蛋白尿水平疗效的Meta分析∗[J].北京中医药大学学报,2016,(2):144-150,7.

基金项目

世界卫生组织(WHO)“在初级卫生保健层面促进重庆市中医药服务研究”(No. WPCHN1408195) (WHO)

北京中医药大学学报

OA北大核心CSCDCSTPCD

1006-2157

访问量0
|
下载量0
段落导航相关论文